Stay updated on Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the page, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T03:08:13.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new publication citation is added to the Publications section: Gimenez-Arnau AM et al. Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naive Patients with Chronic Spontaneous Urticaria. Dermatol Ther (Heidelb). 2026 Jan;16(1):549-562 (doi:10.1007/s13555-025-01605-w; Epub 2025 Dec 2). The prior 2025 Dec 2 'Online ahead of print' entry is removed.
    Difference
    0.0%
    Check dated 2026-03-05T00:31:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a new publication reference: Casale TB, Saini SS, Ben-Shoshan M, Gimenez-Arnau AM, Bernstein JA, Hayama K, Amin N, Robinson LB, Bauer D, Dakin P, Laws E, Radin A, Makhija M. Dupilumab in Patients With Chronic Spontaneous Urticaria: Phase 3 LIBERTY-CSU CUPID Randomized Clinical Trials. JAMA Dermatol. 2026 Feb 18:e256023.
    Difference
    0.0%
    Check dated 2026-02-25T20:20:45.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 is shown on the page. The funding/status notices have been removed (including the lapse in government funding message and the earlier Revision: v3.4.1 reference).
    Difference
    0.2%
    Check dated 2026-02-11T11:39:34.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A site-wide notice regarding a lapse in government funding is displayed, stating information may not be up to date and transactions may not be processed. The page also shows a revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T10:21:16.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Editorial/metadata updates include showing the glossary, updating the QC criteria label, capitalization tweaks for FEAR Act data, and a new revision tag (v3.4.0), and these changes do not affect the core study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:14:44.000Z thumbnail image

Stay in the know with updates to Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.